Silver Book Fact

5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.

Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure. The American Journal of Medicine Web site. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14715324&dopt=Abstract. Published 2004

Reference

Title
Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure
Publication
The American Journal of Medicine
Publisher
Elsevier
Publication Date
Published 2004
Authors
Cowper, P.A., E. DeLong, D.J. Whellan, N.M. Allen LaPointe, and R.M. Califf
Volume & Issue
Volume 116, Issue 2
Pages
104-111
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Increased use of a blood-thinning drug prevents 40,000 strokes every year in the U.S.  
  • 277 medicines are currently in development to treat or prevent heart disease and stroke.  
  • A major objective is to control blood pressure and preempt primary and secondary stroke. Assessing specific antihypertensive therapies will identify specific treatments that will lower blood pressure.  
  • Improvements in QoL from TAVR in SAS patients
    Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state)…  
  • According to the National Institutes of Health, use of the clot-busting drug t-PA saves $4,400 per patient in hospitalization and nursing home costs.